课题基金 / 基金详情

Hypoxia-inducible ERO1-α acts as a member of pre-peptide loading complex and regulates immune responses in the context of MHC class I and class II molecules

Hypoxia-inducible ERO1-α acts as a member of pre-peptide loading complex and regulates immune responses in the context of MHC class I and class II molecules
缺氧诱导的 ERO1-α 作为前肽加载复合物的成员,在 MHC I 类和 II 类分子的背景下调节免疫反应
批准号:
21590400
负责人:
TAMURA Yasuaki
金额:
$3.08万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2009
资助国家:
日本
项目状态:
已结题
起止时间:
2009 至 2011

项目摘要

项目成果

TAMURA Yasuaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The human endoplasmic reticulum oxidoreductin like(ERO1-α) is an oxidizing enzyme that exists in endoplasmic reticulum and is induced under stress environment such as the hypoxia. It regulates a redox state of various kinds of protein through protein disulfide isomerase(PDI). Interestingly, although the expression of ERO1-α in the normal tissue was comparatively limited, various types of cancer cells expressed the large amount of ERO1-α. As the major histocompatibility complex(MHC) class I molecule carries the intramolecular disulfide bonds, we examined whether the hERO1-La plays a role in the oxidative folding and the expression of MHC class I molecules in cancer cells. We established ERO1-α overexpressed and knockdown SW480 cells. As a result, surface expression of MHC class I molecule was up-regulated in the ERO1-α-overexpressed SW480 and down-regulated in the ERO1-α knockdown SW480. Moreover, we have observed that the oxidized form of MHC class I was increased in the hERO1-La-overe … More xpressed SW480. In addition, we have observed that the hERO1-La knockdown SW480 have an impaired response to cytotoxic T lymphocyte(CTL). Interestingly, ERO1-α is highly expressed in the antigen presenting cells such as B cells and dendritic cells among the normal cells. As the major histocompatibility complex(MHC) class II molecule also carries the intramolecular disulfide bonds, we examined whether the ERO1-α plays a role in the oxidative folding and the expression of MHC class II molecules in B cell line. Because human B cell lymphoma line BALL-1 showed high expression of ERO1-α, we generated BALL-1 cells with ERO1-α knockdown using shRNA. As a result, surface expression of MHC class II molecule was down-regulated in the ERO1-Lα-knockdown cells compared to wild type cells. Moreover, knockdown of hERO1-α resulted in the decrease of oxidized form of MHC class II, thereby decreasing the stable peptide-MHC class II complexes. These data suggested that ERO1-α may play an important role in the immune responses against foreign antigens. These data suggested that the ERO1-α regulates immune response via modulation of MHC class I and class II expression and the quality. Less
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
自然免疫内因性リガンドとしてのストレス蛋白質による自己免疫疾患病態制御
通过应激蛋白作为先天免疫内源配体控制自身免疫性疾病病理
DOI: --
发表时间: 2009
期刊:
影响因子: --
作者: [久木田和晴, 田村保明, 田村保明, Tamura Y., 田村保明]
通讯作者: 田村保明
Targeting to Static Endosome is Required for Efficient Cross-Presentation of ER-resident Oxygen Regulated Protein 150-Peptide Complexes
内质网驻留氧调节蛋白 150 肽复合物的有效交叉呈递需要靶向静态内体
DOI: --
发表时间: 2009
期刊: J Immunol
影响因子: 4.4
作者: [Kutomi G, Tamura Y.]
通讯作者: Tamura Y.
DOI: 10.1111/j.1349-7006.2010.01623.x
发表时间: 2010-09-01
期刊: CANCER SCIENCE
影响因子: 5.7
作者: [Sato, Akiko, Tamura, Yasuaki, Jimbow, Kowichi]
通讯作者: Jimbow, Kowichi
インターフェロンα産生阻害剤
干扰素α产生抑制剂
DOI: --
发表时间: 2010
期刊:
影响因子: --
作者: []
通讯作者:
20
    The development of combined cancer therapy targeting hypoxic microenvironment
    Induction of tumor antigen-specific CTL by Hsp90-antigen fusion DNA vaccine
    • 批准号:
      19590357
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.0万
    • 财政年份:
      2007
    • 负责人:
      TAMURA Yasuaki
    • 依托单位:
    Identification of Hsp90-specific receptor expressed on human dendritic cells and its application for cancer immunothearpy
    • 批准号:
      17590309
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.37万
    • 财政年份:
      2005
    • 负责人:
      TAMURA Yasuaki
    • 依托单位:
    Development of novel antitumor immunogenetherapy using artificial cancer antigen-secreting tumors.
    • 批准号:
      15590353
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2003
    • 负责人:
      TAMURA Yasuaki
    • 依托单位:
    国内基金
    海外基金
    ERO1α经MAMs促线粒体钙摄取在氧化应激致猪卵泡闭锁中的作用及机制
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      刘琪
    • 依托单位:
    ERO1α协同KRAS促进胰腺炎癌转化的机制研究
    • 批准号:
      82372622
    • 项目类别:
      面上项目
    • 资助金额:
      49万元
    • 批准年份:
      2023
    • 负责人:
      花荣
    • 依托单位:
    平滑肌细胞中Ero1α在肺动脉高压血管重构中的作用和机制研究
    • 批准号:
      82300078
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      江红霞
    • 依托单位:
    Ero1α经MAMs促线粒体钙摄取在DEHP致未成熟睾丸血睾屏障损伤中的机制研究
    • 批准号:
      82301793
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      30万元
    • 批准年份:
      2023
    • 负责人:
      王军可
    • 依托单位: